Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
Inserm · Institut Gustave Roussy · +16 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
917
total citations
- FWCI
- 57.76
- Percentile
- 100%
- References
- 78
Citations per year
Authors
45- ASAymeric Silvin
Inserm, Institut Gustave Roussy
- NCNicolas Chapuis
Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Institut Cochin
- GDGarett Dunsmore
Inserm, Institut Gustave Roussy
- AGAnne‐Gaëlle Goubet
Inserm, Institut Gustave Roussy
- ADAgathe Dubuisson
Inserm, Institut Gustave Roussy
Topics & keywords
Topics
Keywords
- Biology
- Myeloid cells
- Coronavirus disease 2019 (COVID-19)
- Calprotectin
- Myeloid
- Immunology
- Virology
- Cell
UN Sustainable Development Goals
- Reduced inequalities
No related works found for this paper.